Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Fentanyl 💬 1件: Fentanyl1件: Fentanyl; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 70, 215 💬
2 Dexmedetomidine 💬 1件: Dexmedetomidine4件: Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE; 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
3 Calcium gluconate 💬 1件: Calcium gluconate1件: Calcium gluconate; --3件: 214, 215, 235 💬
4 Ubidecarenone 💬 1件: Ubidecarenone3件: Coenzyme Q-10; Coenzyme Q10; CoQ10; --12件: 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 💬
5 Eplerenone 💬 1件: Eplerenone1件: Eplerenone; 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215 💬
6 Tranexamic acid 💬 1件: Tranexamic acid1件: Tranexamic acid; 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 70, 215, 227, 274, 288, 299 💬
7 Sodium citrate hydrate 💬 1件: Sodium citrate1件: Sodium citrate; --4件: 67, 214, 215, 235 💬
8 Artesunate 💬 1件: Artesunate1件: Artesunate; --3件: 18, 66, 96 💬
9 Dobutamine 💬 1件: Dobutamine2件: Dobutamin; Dobutamine; 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 86, 215 💬
10 Sodium citrate 💬 1件: Sodium citrate1件: Sodium citrate; --4件: 67, 214, 215, 235 💬
11 Sulfur hexafluoride 💬 1件: Sulfur hexafluoride3件: SonoVue; SULFUR HEXAFLUORIDE; Sulphur hexafluoride; --2件: 96, 215 💬
12 Ketamine 💬 1件: Ketamine2件: Ketamine; NMDA; 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
13 Losartan 💬 1件: Losartan3件: Cozaar; Losartan; Losartan Potassium; 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
14 Potassium 💬 1件: Potassium1件: Potassium; --13件: 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 💬